Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sinusitis | 45 | 2023 | 995 | 7.060 |
Why?
|
Endoscopy | 62 | 2024 | 1841 | 6.980 |
Why?
|
Rhinitis | 30 | 2023 | 752 | 6.240 |
Why?
|
Paranasal Sinuses | 15 | 2021 | 267 | 3.830 |
Why?
|
Dacryocystorhinostomy | 10 | 2024 | 78 | 3.650 |
Why?
|
Nasal Polyps | 16 | 2022 | 412 | 3.430 |
Why?
|
Frontal Sinus | 8 | 2017 | 51 | 2.150 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 12 | 2015 | 325 | 2.150 |
Why?
|
Decompression, Surgical | 10 | 2024 | 603 | 2.000 |
Why?
|
Paranasal Sinus Diseases | 8 | 2020 | 121 | 1.820 |
Why?
|
Lacrimal Duct Obstruction | 5 | 2024 | 53 | 1.650 |
Why?
|
Natural Orifice Endoscopic Surgery | 4 | 2019 | 119 | 1.590 |
Why?
|
Frontal Sinusitis | 8 | 2013 | 19 | 1.580 |
Why?
|
Graves Ophthalmopathy | 7 | 2024 | 135 | 1.490 |
Why?
|
Lacrimal Apparatus Diseases | 2 | 2024 | 72 | 1.450 |
Why?
|
Orbit | 12 | 2024 | 456 | 1.340 |
Why?
|
Chronic Disease | 44 | 2023 | 9347 | 1.250 |
Why?
|
Turbinates | 6 | 2019 | 66 | 1.230 |
Why?
|
Nasal Mucosa | 8 | 2012 | 416 | 1.140 |
Why?
|
Nasolacrimal Duct | 4 | 2020 | 79 | 0.940 |
Why?
|
Exophthalmos | 5 | 2014 | 99 | 0.930 |
Why?
|
Tissue Adhesions | 6 | 2019 | 220 | 0.920 |
Why?
|
Cell Adhesion Molecules | 4 | 2019 | 1612 | 0.880 |
Why?
|
Decision Trees | 5 | 2020 | 509 | 0.850 |
Why?
|
Quality of Life | 16 | 2023 | 13462 | 0.840 |
Why?
|
Tears | 1 | 2024 | 254 | 0.790 |
Why?
|
Reoperation | 12 | 2019 | 4294 | 0.700 |
Why?
|
Hemangioma, Cavernous | 3 | 2019 | 105 | 0.690 |
Why?
|
Psychotherapeutic Processes | 1 | 2020 | 50 | 0.690 |
Why?
|
Dilatation | 2 | 2020 | 310 | 0.680 |
Why?
|
Dacryocystitis | 1 | 2020 | 67 | 0.670 |
Why?
|
Sphenoid Bone | 4 | 2010 | 176 | 0.640 |
Why?
|
Sensory Thresholds | 1 | 2020 | 377 | 0.620 |
Why?
|
Orbital Neoplasms | 3 | 2019 | 223 | 0.620 |
Why?
|
Debridement | 2 | 2014 | 495 | 0.600 |
Why?
|
Graves Disease | 6 | 2010 | 241 | 0.590 |
Why?
|
Surgery, Computer-Assisted | 6 | 2008 | 993 | 0.590 |
Why?
|
Otolaryngology | 4 | 2015 | 698 | 0.590 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2014 | 445 | 0.580 |
Why?
|
Olfaction Disorders | 1 | 2020 | 223 | 0.580 |
Why?
|
Postoperative Complications | 23 | 2019 | 15747 | 0.570 |
Why?
|
Osteotomy | 5 | 2013 | 833 | 0.560 |
Why?
|
Eye Neoplasms | 1 | 2019 | 304 | 0.550 |
Why?
|
Ethmoid Sinusitis | 3 | 2011 | 25 | 0.550 |
Why?
|
Eustachian Tube | 3 | 2007 | 99 | 0.550 |
Why?
|
Treatment Outcome | 38 | 2024 | 65188 | 0.550 |
Why?
|
Granuloma | 1 | 2019 | 327 | 0.550 |
Why?
|
Optic Nerve Diseases | 4 | 2009 | 343 | 0.520 |
Why?
|
Drug-Eluting Stents | 2 | 2020 | 683 | 0.510 |
Why?
|
Cost-Benefit Analysis | 6 | 2020 | 5526 | 0.510 |
Why?
|
Sphenoid Sinusitis | 2 | 2010 | 10 | 0.490 |
Why?
|
Psychometrics | 3 | 2024 | 3062 | 0.490 |
Why?
|
Speech | 2 | 2017 | 555 | 0.490 |
Why?
|
Rhinoplasty | 1 | 2019 | 241 | 0.480 |
Why?
|
Lacrimal Apparatus | 1 | 2017 | 224 | 0.480 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 2 | 2012 | 86 | 0.470 |
Why?
|
Mucocele | 2 | 2013 | 51 | 0.450 |
Why?
|
Ethmoid Sinus | 4 | 2011 | 58 | 0.440 |
Why?
|
Middle Aged | 77 | 2024 | 223009 | 0.440 |
Why?
|
Postoperative Care | 3 | 2019 | 1470 | 0.440 |
Why?
|
Laryngoscopy | 2 | 2016 | 686 | 0.430 |
Why?
|
Maxillary Sinus | 1 | 2014 | 172 | 0.420 |
Why?
|
Optic Nerve | 2 | 2007 | 567 | 0.420 |
Why?
|
Diplopia | 5 | 2016 | 217 | 0.420 |
Why?
|
Conflict of Interest | 1 | 2018 | 556 | 0.420 |
Why?
|
Ethmoid Bone | 5 | 2009 | 35 | 0.410 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2015 | 243 | 0.400 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2012 | 74 | 0.400 |
Why?
|
Humans | 131 | 2024 | 765968 | 0.400 |
Why?
|
Prospective Studies | 27 | 2023 | 54802 | 0.390 |
Why?
|
Male | 88 | 2024 | 363698 | 0.390 |
Why?
|
Choline O-Acetyltransferase | 1 | 2012 | 154 | 0.390 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2008 | 8923 | 0.380 |
Why?
|
Female | 86 | 2024 | 396112 | 0.360 |
Why?
|
Adult | 67 | 2024 | 223044 | 0.360 |
Why?
|
Laser Therapy | 5 | 2007 | 1108 | 0.360 |
Why?
|
Follow-Up Studies | 25 | 2023 | 39193 | 0.350 |
Why?
|
Skull Base | 2 | 2012 | 293 | 0.350 |
Why?
|
Quality-Adjusted Life Years | 5 | 2020 | 1737 | 0.350 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 830 | 0.340 |
Why?
|
Facial Nerve | 7 | 1993 | 277 | 0.340 |
Why?
|
Asthma | 6 | 2017 | 6270 | 0.330 |
Why?
|
Tomography, X-Ray Computed | 23 | 2014 | 20659 | 0.330 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 1061 | 0.330 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1514 | 0.330 |
Why?
|
Models, Economic | 4 | 2017 | 716 | 0.330 |
Why?
|
Health Status Indicators | 1 | 2014 | 966 | 0.320 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1808 | 0.320 |
Why?
|
Aged | 50 | 2024 | 171117 | 0.310 |
Why?
|
Markov Chains | 3 | 2017 | 968 | 0.310 |
Why?
|
Otitis Media with Effusion | 2 | 2007 | 115 | 0.300 |
Why?
|
Free Tissue Flaps | 1 | 2012 | 335 | 0.300 |
Why?
|
Epistaxis | 4 | 2013 | 119 | 0.280 |
Why?
|
Frontal Bone | 1 | 2007 | 105 | 0.280 |
Why?
|
Autonomic Nervous System | 1 | 2012 | 706 | 0.280 |
Why?
|
Retrospective Studies | 26 | 2020 | 81514 | 0.280 |
Why?
|
Faculty, Medical | 1 | 2015 | 1219 | 0.270 |
Why?
|
Medicare | 3 | 2024 | 6823 | 0.270 |
Why?
|
Eosinophilia | 3 | 2003 | 556 | 0.260 |
Why?
|
Ear Diseases | 2 | 2007 | 179 | 0.250 |
Why?
|
Imaging, Three-Dimensional | 3 | 2008 | 4034 | 0.230 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2007 | 354 | 0.220 |
Why?
|
Sickness Impact Profile | 3 | 2005 | 297 | 0.220 |
Why?
|
Optics and Photonics | 3 | 2000 | 305 | 0.220 |
Why?
|
Ointment Bases | 1 | 2003 | 3 | 0.220 |
Why?
|
Tampons, Surgical | 1 | 2003 | 10 | 0.220 |
Why?
|
Nasal Cavity | 3 | 2015 | 307 | 0.210 |
Why?
|
Osteoma | 1 | 2003 | 12 | 0.210 |
Why?
|
Intraoperative Complications | 4 | 2013 | 1162 | 0.210 |
Why?
|
Drug Hypersensitivity | 2 | 2009 | 902 | 0.200 |
Why?
|
Foreign-Body Reaction | 1 | 2003 | 153 | 0.200 |
Why?
|
Age Factors | 2 | 2018 | 18380 | 0.200 |
Why?
|
Skull Neoplasms | 1 | 2003 | 173 | 0.190 |
Why?
|
Software | 2 | 2014 | 4462 | 0.190 |
Why?
|
Microsurgery | 1 | 2007 | 795 | 0.190 |
Why?
|
Mitomycin | 1 | 2002 | 261 | 0.190 |
Why?
|
Fibroma | 1 | 2003 | 197 | 0.180 |
Why?
|
Neural Pathways | 1 | 2012 | 3085 | 0.180 |
Why?
|
Aged, 80 and over | 20 | 2018 | 59489 | 0.180 |
Why?
|
Intraoperative Care | 2 | 2004 | 760 | 0.170 |
Why?
|
Visual Acuity | 4 | 2016 | 2708 | 0.170 |
Why?
|
Aspirin | 2 | 2009 | 3134 | 0.170 |
Why?
|
Intraoperative Period | 2 | 2019 | 508 | 0.170 |
Why?
|
Nerve Compression Syndromes | 2 | 2014 | 159 | 0.160 |
Why?
|
Cohort Studies | 9 | 2021 | 41649 | 0.160 |
Why?
|
Gene Expression Profiling | 3 | 2011 | 9525 | 0.150 |
Why?
|
Time Factors | 7 | 2023 | 40065 | 0.150 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2002 | 679 | 0.150 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2268 | 0.150 |
Why?
|
Smell | 1 | 2020 | 259 | 0.150 |
Why?
|
Fistula | 2 | 1992 | 212 | 0.140 |
Why?
|
Patient Satisfaction | 3 | 2014 | 3475 | 0.140 |
Why?
|
Academic Medical Centers | 3 | 2016 | 2780 | 0.140 |
Why?
|
Hemangiopericytoma | 1 | 1997 | 71 | 0.140 |
Why?
|
Treatment Failure | 2 | 2017 | 2652 | 0.140 |
Why?
|
Activities of Daily Living | 3 | 2014 | 2415 | 0.140 |
Why?
|
Adenoidectomy | 1 | 2018 | 171 | 0.140 |
Why?
|
Nasal Obstruction | 1 | 2019 | 162 | 0.130 |
Why?
|
Eosinophils | 1 | 2001 | 945 | 0.130 |
Why?
|
Absorbable Implants | 1 | 2019 | 333 | 0.130 |
Why?
|
Maxillary Artery | 2 | 1988 | 18 | 0.130 |
Why?
|
Intubation | 2 | 2013 | 141 | 0.130 |
Why?
|
Papilloma, Inverted | 1 | 2015 | 19 | 0.130 |
Why?
|
History, 20th Century | 3 | 2015 | 2761 | 0.120 |
Why?
|
Video-Assisted Surgery | 2 | 2007 | 48 | 0.120 |
Why?
|
Radiology, Interventional | 1 | 1999 | 485 | 0.120 |
Why?
|
Health Care Costs | 2 | 2019 | 3242 | 0.120 |
Why?
|
Tonsillectomy | 1 | 2018 | 284 | 0.120 |
Why?
|
Hypertrophy | 2 | 2007 | 559 | 0.120 |
Why?
|
Adolescent | 19 | 2018 | 88835 | 0.110 |
Why?
|
Palliative Care | 1 | 2009 | 3645 | 0.110 |
Why?
|
Mucous Membrane | 2 | 2007 | 657 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 1995 | 276 | 0.110 |
Why?
|
Ligation | 3 | 2013 | 444 | 0.110 |
Why?
|
Private Practice | 1 | 2014 | 154 | 0.100 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20124 | 0.100 |
Why?
|
Reimbursement Mechanisms | 1 | 2018 | 672 | 0.100 |
Why?
|
Salivary Gland Fistula | 1 | 1992 | 1 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1008 | 0.100 |
Why?
|
Biological Products | 1 | 2022 | 942 | 0.100 |
Why?
|
Palate, Hard | 1 | 2012 | 59 | 0.100 |
Why?
|
Eyelid Diseases | 1 | 2014 | 155 | 0.100 |
Why?
|
Curettage | 2 | 2007 | 74 | 0.100 |
Why?
|
Health Status | 4 | 2000 | 4080 | 0.100 |
Why?
|
Hospitals, University | 1 | 2014 | 574 | 0.100 |
Why?
|
Interprofessional Relations | 1 | 2018 | 999 | 0.100 |
Why?
|
Dissection | 2 | 2009 | 299 | 0.090 |
Why?
|
Therapeutic Irrigation | 1 | 2013 | 297 | 0.090 |
Why?
|
Barium Sulfate | 1 | 1992 | 180 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1880 | 0.090 |
Why?
|
Receptors, Thyrotropin | 1 | 2010 | 46 | 0.090 |
Why?
|
Pharyngeal Diseases | 1 | 1992 | 133 | 0.090 |
Why?
|
Young Adult | 6 | 2018 | 59889 | 0.090 |
Why?
|
Otitis Media, Suppurative | 1 | 1990 | 27 | 0.090 |
Why?
|
Nasopharyngeal Diseases | 1 | 1990 | 27 | 0.090 |
Why?
|
Dental Implantation, Endosseous | 1 | 2014 | 520 | 0.090 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12056 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3807 | 0.090 |
Why?
|
Consensus | 2 | 2021 | 3202 | 0.090 |
Why?
|
Nose Neoplasms | 1 | 2012 | 249 | 0.080 |
Why?
|
Laryngectomy | 1 | 1992 | 244 | 0.080 |
Why?
|
Recovery of Function | 1 | 2020 | 2966 | 0.080 |
Why?
|
Adipokines | 2 | 2011 | 308 | 0.080 |
Why?
|
Video Recording | 2 | 1992 | 969 | 0.080 |
Why?
|
Incidence | 4 | 2020 | 21480 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2009 | 7478 | 0.080 |
Why?
|
United States | 5 | 2024 | 72903 | 0.080 |
Why?
|
Seasons | 1 | 2015 | 1524 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2015 | 9373 | 0.080 |
Why?
|
Enophthalmos | 1 | 2008 | 34 | 0.080 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2008 | 57 | 0.080 |
Why?
|
Cost of Illness | 1 | 1998 | 1950 | 0.070 |
Why?
|
Biopsy | 2 | 2019 | 6763 | 0.070 |
Why?
|
Data Collection | 2 | 2014 | 3318 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2011 | 561 | 0.070 |
Why?
|
Facial Paralysis | 2 | 2001 | 346 | 0.070 |
Why?
|
Electromagnetic Phenomena | 2 | 1999 | 160 | 0.070 |
Why?
|
Otitis Media | 1 | 1990 | 287 | 0.070 |
Why?
|
Magnetics | 1 | 1991 | 585 | 0.070 |
Why?
|
Drainage | 4 | 2004 | 1179 | 0.070 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2008 | 87 | 0.070 |
Why?
|
Blood Loss, Surgical | 2 | 2005 | 629 | 0.070 |
Why?
|
Surgery, Plastic | 1 | 1994 | 651 | 0.070 |
Why?
|
Eye Diseases | 1 | 2013 | 659 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2008 | 371 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11022 | 0.070 |
Why?
|
Optic Neuritis | 1 | 2008 | 172 | 0.070 |
Why?
|
Palate | 1 | 2007 | 126 | 0.070 |
Why?
|
Chyle | 1 | 1986 | 17 | 0.070 |
Why?
|
Protein Array Analysis | 1 | 2008 | 399 | 0.070 |
Why?
|
Autoantigens | 1 | 2010 | 883 | 0.070 |
Why?
|
Omeprazole | 1 | 2007 | 106 | 0.070 |
Why?
|
Audiometry, Pure-Tone | 1 | 2007 | 210 | 0.070 |
Why?
|
Membrane Transport Proteins | 2 | 2011 | 1028 | 0.070 |
Why?
|
Anti-Ulcer Agents | 1 | 2007 | 112 | 0.060 |
Why?
|
Sclerosing Solutions | 1 | 1986 | 80 | 0.060 |
Why?
|
Methods | 3 | 1995 | 1052 | 0.060 |
Why?
|
Endoscopes | 1 | 2007 | 168 | 0.060 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2008 | 640 | 0.060 |
Why?
|
Pseudomonas Infections | 1 | 1990 | 622 | 0.060 |
Why?
|
Tetracycline | 1 | 1986 | 216 | 0.060 |
Why?
|
Phenotype | 2 | 2017 | 16721 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 1999 | 3529 | 0.060 |
Why?
|
Respiratory Hypersensitivity | 1 | 2007 | 271 | 0.060 |
Why?
|
Tympanic Membrane | 1 | 2007 | 233 | 0.060 |
Why?
|
Electrophysiology | 1 | 1988 | 1263 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4562 | 0.060 |
Why?
|
Neck Dissection | 1 | 1986 | 200 | 0.060 |
Why?
|
Down-Regulation | 2 | 2011 | 2927 | 0.060 |
Why?
|
Arteries | 2 | 2007 | 1118 | 0.060 |
Why?
|
Clinical Competence | 1 | 2000 | 4863 | 0.060 |
Why?
|
Glycoproteins | 2 | 2011 | 2195 | 0.060 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 1985 | 240 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11206 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3685 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15880 | 0.050 |
Why?
|
Reference Values | 1 | 2010 | 4908 | 0.050 |
Why?
|
Skin Diseases | 1 | 1992 | 1088 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 14071 | 0.050 |
Why?
|
Corneal Diseases | 1 | 2009 | 535 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1936 | 0.050 |
Why?
|
Hearing | 1 | 2007 | 505 | 0.050 |
Why?
|
Hemostasis, Surgical | 1 | 2003 | 127 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2003 | 268 | 0.050 |
Why?
|
Vacuoles | 1 | 2003 | 224 | 0.050 |
Why?
|
Physicians | 1 | 2000 | 4588 | 0.050 |
Why?
|
Facial Pain | 1 | 2003 | 118 | 0.050 |
Why?
|
Evoked Potentials | 1 | 1988 | 1048 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2004 | 22223 | 0.050 |
Why?
|
Proton Pump Inhibitors | 1 | 2007 | 553 | 0.050 |
Why?
|
Otologic Surgical Procedures | 1 | 2003 | 148 | 0.050 |
Why?
|
Stents | 1 | 2013 | 3213 | 0.050 |
Why?
|
Vision Disorders | 1 | 2008 | 1087 | 0.050 |
Why?
|
Sarcoma | 1 | 2012 | 1802 | 0.050 |
Why?
|
Metaproterenol | 1 | 1980 | 3 | 0.040 |
Why?
|
Decision Making | 1 | 2014 | 3965 | 0.040 |
Why?
|
Aminophylline | 1 | 1980 | 41 | 0.040 |
Why?
|
Computer Simulation | 1 | 2014 | 6255 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 1988 | 1792 | 0.040 |
Why?
|
Carotid Body Tumor | 1 | 1980 | 32 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4618 | 0.040 |
Why?
|
Eye Infections | 1 | 2000 | 63 | 0.040 |
Why?
|
Gastroesophageal Reflux | 1 | 2007 | 833 | 0.040 |
Why?
|
Recurrence | 4 | 2008 | 8501 | 0.040 |
Why?
|
Glaucoma | 1 | 2008 | 1194 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2011 | 4913 | 0.040 |
Why?
|
Arkansas | 1 | 2018 | 59 | 0.040 |
Why?
|
Paraganglioma | 1 | 1980 | 143 | 0.040 |
Why?
|
Facial Muscles | 2 | 1991 | 159 | 0.040 |
Why?
|
Gene Expression | 1 | 2011 | 7584 | 0.040 |
Why?
|
Orbital Diseases | 1 | 2000 | 178 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2001 | 912 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 2844 | 0.040 |
Why?
|
Postoperative Period | 2 | 2005 | 1816 | 0.040 |
Why?
|
Parotid Neoplasms | 2 | 1991 | 157 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2001 | 1602 | 0.040 |
Why?
|
Social Adjustment | 1 | 2000 | 633 | 0.040 |
Why?
|
Patient Selection | 2 | 2009 | 4255 | 0.030 |
Why?
|
Kartagener Syndrome | 1 | 1997 | 33 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2005 | 1677 | 0.030 |
Why?
|
Speech Acoustics | 1 | 1997 | 155 | 0.030 |
Why?
|
Absenteeism | 1 | 1998 | 246 | 0.030 |
Why?
|
Head and Neck Neoplasms | 2 | 1988 | 2921 | 0.030 |
Why?
|
Therapy, Computer-Assisted | 1 | 1998 | 265 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14652 | 0.030 |
Why?
|
Headache | 1 | 2003 | 1259 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 893 | 0.030 |
Why?
|
Risk Factors | 3 | 2016 | 74840 | 0.030 |
Why?
|
Ischemia | 1 | 1983 | 1909 | 0.030 |
Why?
|
Holmium | 1 | 1994 | 29 | 0.030 |
Why?
|
Electric Stimulation | 2 | 1991 | 1735 | 0.030 |
Why?
|
Yttrium | 1 | 1994 | 33 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1668 | 0.030 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2015 | 184 | 0.030 |
Why?
|
Sphenoid Sinus | 1 | 1994 | 100 | 0.030 |
Why?
|
Work | 1 | 1995 | 195 | 0.030 |
Why?
|
Monitoring, Intraoperative | 1 | 2000 | 936 | 0.030 |
Why?
|
Office Visits | 1 | 1998 | 595 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2001 | 1820 | 0.030 |
Why?
|
Ohio | 1 | 1994 | 320 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 1983 | 1403 | 0.030 |
Why?
|
Blepharospasm | 1 | 1993 | 34 | 0.030 |
Why?
|
Cautery | 1 | 2013 | 73 | 0.030 |
Why?
|
Proteus Infections | 1 | 1992 | 10 | 0.030 |
Why?
|
Pain | 2 | 2000 | 5077 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2000 | 1432 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1995 | 457 | 0.020 |
Why?
|
Oculomotor Muscles | 1 | 1996 | 404 | 0.020 |
Why?
|
Single-Blind Method | 1 | 1996 | 1589 | 0.020 |
Why?
|
Action Potentials | 2 | 1991 | 1838 | 0.020 |
Why?
|
Strabismus | 1 | 1996 | 320 | 0.020 |
Why?
|
Edema | 1 | 1996 | 760 | 0.020 |
Why?
|
Radiography | 2 | 2013 | 6919 | 0.020 |
Why?
|
Surgical Instruments | 1 | 1994 | 377 | 0.020 |
Why?
|
Necrosis | 1 | 1996 | 1617 | 0.020 |
Why?
|
Bandages | 1 | 2013 | 269 | 0.020 |
Why?
|
Botulinum Toxins | 1 | 1993 | 191 | 0.020 |
Why?
|
Observer Variation | 1 | 1997 | 2615 | 0.020 |
Why?
|
Silicone Elastomers | 1 | 1991 | 78 | 0.020 |
Why?
|
Maxilla | 1 | 1994 | 485 | 0.020 |
Why?
|
Statistics as Topic | 1 | 1997 | 2352 | 0.020 |
Why?
|
Adenoma, Pleomorphic | 1 | 1991 | 76 | 0.020 |
Why?
|
Acute Disease | 2 | 2016 | 7232 | 0.020 |
Why?
|
Nose | 1 | 1994 | 519 | 0.020 |
Why?
|
Nose Diseases | 1 | 1991 | 79 | 0.020 |
Why?
|
Receptors, Growth Factor | 1 | 2011 | 324 | 0.020 |
Why?
|
Boston | 1 | 2003 | 9338 | 0.020 |
Why?
|
Nasal Septum | 1 | 1991 | 130 | 0.020 |
Why?
|
Drug Costs | 1 | 1998 | 1193 | 0.020 |
Why?
|
Carotid Artery, External | 1 | 1989 | 37 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 1600 | 0.020 |
Why?
|
Rhabdomyosarcoma | 1 | 2012 | 354 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2387 | 0.020 |
Why?
|
Sarcoma, Kaposi | 1 | 2012 | 375 | 0.020 |
Why?
|
Self Concept | 1 | 1995 | 1037 | 0.020 |
Why?
|
Laryngeal Diseases | 1 | 1992 | 248 | 0.020 |
Why?
|
Immunocompetence | 1 | 2008 | 138 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1995 | 1172 | 0.020 |
Why?
|
Child | 5 | 2016 | 80564 | 0.020 |
Why?
|
Voice Disorders | 1 | 1992 | 286 | 0.020 |
Why?
|
Emotions | 1 | 2000 | 2763 | 0.020 |
Why?
|
Sex Distribution | 1 | 2012 | 2263 | 0.020 |
Why?
|
SEER Program | 1 | 2012 | 1446 | 0.020 |
Why?
|
Catheterization | 1 | 1992 | 1425 | 0.020 |
Why?
|
Cats | 1 | 1988 | 972 | 0.020 |
Why?
|
Age Distribution | 1 | 2012 | 2858 | 0.020 |
Why?
|
Prognosis | 4 | 2012 | 29922 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2011 | 1130 | 0.020 |
Why?
|
Linear Models | 1 | 1996 | 5876 | 0.020 |
Why?
|
Mental Health | 1 | 2000 | 3278 | 0.020 |
Why?
|
Mycoses | 1 | 2008 | 389 | 0.020 |
Why?
|
Health Surveys | 1 | 1995 | 4056 | 0.020 |
Why?
|
Wound Healing | 1 | 1996 | 2792 | 0.010 |
Why?
|
Reaction Time | 1 | 1991 | 2086 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5020 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1992 | 1393 | 0.010 |
Why?
|
Acoustic Impedance Tests | 1 | 2003 | 111 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8875 | 0.010 |
Why?
|
Radiotherapy | 1 | 1989 | 1494 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4137 | 0.010 |
Why?
|
Middle Ear Ventilation | 1 | 2003 | 101 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6069 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1989 | 1181 | 0.010 |
Why?
|
Dogs | 1 | 1985 | 3822 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1992 | 2778 | 0.010 |
Why?
|
Child, Preschool | 1 | 2003 | 42500 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 1991 | 8529 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10070 | 0.010 |
Why?
|
Preoperative Care | 1 | 2009 | 2267 | 0.010 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 1984 | 537 | 0.010 |
Why?
|
Focus Groups | 1 | 2005 | 1459 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4392 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10603 | 0.010 |
Why?
|
Cellulitis | 1 | 2000 | 206 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7599 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8067 | 0.010 |
Why?
|
Abscess | 1 | 2000 | 606 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 2 | 1989 | 4044 | 0.010 |
Why?
|
Length of Stay | 1 | 1988 | 6485 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12976 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1997 | 2548 | 0.010 |
Why?
|
Cilia | 1 | 1997 | 499 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2003 | 5302 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1980 | 6309 | 0.010 |
Why?
|
Vasa Vasorum | 1 | 1989 | 25 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1986 | 6364 | 0.000 |
Why?
|
Primary Health Care | 1 | 2005 | 4736 | 0.000 |
Why?
|
Rupture | 1 | 1989 | 443 | 0.000 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1989 | 869 | 0.000 |
Why?
|
Nerve Regeneration | 1 | 1993 | 802 | 0.000 |
Why?
|
Animals | 2 | 1988 | 168764 | 0.000 |
Why?
|
Oropharyngeal Neoplasms | 1 | 1989 | 492 | 0.000 |
Why?
|
Pharyngitis | 1 | 1984 | 221 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36532 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1993 | 10729 | 0.000 |
Why?
|